Research activities carried out at Casa di Cura Privata del Policlinico are formally recognised through:

  • Registration in the National Register of Records, art. 64, paragraph 1, Presidential Decree 11 July 1980 n ° 382 with communication of 29.10.2012 prot. 238 \ 343 of the Ministry of Education, University and Research;
  • Recognition by the Lombardy Region to Center for Cognitive Disorders and Dementia (CDCD), on 24.02.2017 and inclusion on the Demenze Observatory Project of the Istituto Superiore di Sanità, qualifying the outpatient activity of the structure for the dementia area;
  • Resolution No. 1220 of 9.09.2014 of ASL Milano for the recognition to “Outpatient Center for the clinical trial of phase I, II, III medicines, for patients only excluding healthy volunteers, pregnant women and those with inferior age at the age of 18 “;
  • Inclusion in 2014 on the AIFA list of the Centers authorized to conduct “clinical pharmacological experimentation”;
  • Recognition on 01.04.2015 with DGR X / 3350 of CCPP as a Presidium of the Regional Network for Rare Diseases, in specific:
    • Amyotrophic lateral sclerosis,
    • Primary Lateral Sclerosis
    • Chronic Inflammatory Demielinizing Polyneuropathy.
  • Registration at the European Commission for participation in Research Bands, through validation by the European Commission’s Research Executive Agency (REA) and assignment of the PIC (Personal Identification Code);
  • Registration with the Lombardy Region for participation in Research Calls, through registration in the Questio system (Quality Evaluation in Science and Technology for Innovation Opportunity), reference registry of the Research and Innovation Centers (CRTT);
  • Inclusion in the Lombard District for Biomedical Innovation, Decree of the Central Planning Integrated Programming Lombardy Region No. 5981 of 5.7.2012, to which regional, national and European funds refer; Accession on 5/01/2015 to the Life Sciences Cluster, an instrument to enhance and revitalize the Life Sciences (LS) sector in Lombardy.